Skip to main content

Table 4 Association between KDM2A protein expression and clinical features in ccRCC

From: Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma

Parameters n KDM2A mRNA expression in ccRCC P
Low, n (%) High, n (%)
Gender     
Male 29 1 (3.4%) 28 (96.6%) 0.181
Female 21 4 (19.0%) 17 (81.0%)  
Age, years     
< 60 28 3 (10.7%) 25 (89.3%) 1.000
≥ 60 22 2 (9.1%) 20 (90.9%)  
Location     
Left 22 2 (9.1%) 20 (90.9%) 1.000
Right 28 3 (10.7%) 25 (89.3%)  
BMI (kg/m2)     
< 24 20 0 (0%) 20 (100%) 0.149
≥ 24 30 5 (16.7%) 25 (83.3%)  
Tumor size (cm)     
≤ 7 35 5 (14.3%) 30 (85.7%) 0.304
> 7 15 0 (0%) 15 (100%)  
Smoking     
No 39 5 (12.8%) 34 (87.2%) 0.495
Yes 11 0 (0%) 11 (100%)  
Thrombus of renal vein     
No 46 5 (10.9%) 41 (89.1%) 1.000
Yes 4 0 (0%) 4 (100%)  
TNM stage     
T1–T2 38 5 (13.2%) 33 (86.8%) 0.440
T3–T4 12 0 (0%) 12 (100%)  
ISUP grade     
1–2 35 4 (11.4%) 31 (88.6%) 1.000
3–4 15 1 (6.7%) 14 (93.3%)  
Symptoms     
No 32 4 (12.5%) 28 (87.5%) 0.768
Yes 18 1 (5.6%) 17 (94.4%)  
Hypertension     
No 29 4 (13.8%) 25 (86.2%) 0.567
Yes 21 1 (4.8%) 20 (95.2%)